The cost-effectiveness of high dose chemotherapy in the treatment of relapsed Hodgkin's disease and non-Hodgkin's lymphoma.

MLA

Beard, S. M., et al. “The Cost-Effectiveness of High Dose Chemotherapy in the Treatment of Relapsed Hodgkin’s Disease and Non-Hodgkin’s Lymphoma.” British Journal of Cancer, vol. 82, no. 1, Jan. 2000, pp. 81–84. EBSCOhost, https://doi.org/10.1054/bjoc.1999.0880.

APA

Beard, S. M., Lorigan, P. C., & Sampson, F. C. (2000). The cost-effectiveness of high dose chemotherapy in the treatment of relapsed Hodgkin’s disease and non-Hodgkin’s lymphoma. British Journal of Cancer, 82(1), 81–84. https://doi.org/10.1054/bjoc.1999.0880

Chicago

Beard, S M, P C Lorigan, and F C Sampson. 2000. “The Cost-Effectiveness of High Dose Chemotherapy in the Treatment of Relapsed Hodgkin’s Disease and Non-Hodgkin’s Lymphoma.” British Journal of Cancer 82 (1): 81–84. doi:10.1054/bjoc.1999.0880.